Halo gets investment from private equity group; 1.5 million bottles of eye drops recalled;

> Afghanistan blames Pakistani counterfeiters and corrupt border officials for a flood of fake meds. Story

> Argos Therapeutics ($ARGS) has struck a deal for Saint-Gobain's Performance Plastics division to design disposables for use in the manufacturing of Argos' lead product candidate. Release

> Workers have gone on strike at an Arvind Remedies plant in Tamil Nadu, India. Report

> Private investment group SK Capital Partners has taken a controlling interest in Whippany, NJ-based contract manufacturer Halo Pharmaceutical. Release

And Finally... K.C. Pharmaceuticals of Pomona, CA, is recalling about 1.5 million bottles of an over-the-counter eye drop solution being sold by retailers across the U.S. because they were stored at a noncompliant facility in Italy. Report

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.